Search research articles
Contact Us
Filters
Showing results (681-690 of 718) with videos related to
Page
of 72
Sort By:
ACS Medicinal Chemistry Letters
|
October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings
Huy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique Properties
Yesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Space Science Reviews
|
February 6, 2026
Geodetic Investigations of the Europa Clipper Mission
G Steinbrügge, R S Park, J H Roberts, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 8, 2001
Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7
G Sansig, T J Bushell, V R Clarke, et al.
Journal of Medicinal Chemistry
|
January 20, 2018
Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties
Eric J Miller, Edgars Jecs, Valarie M Truax, et al.
Brain Structure & Function
|
August 21, 2025
Multi-centre normative brain mapping of intracranial EEG lifespan patterns in the human brain
Heather Woodhouse, Gerard Hall, Callum Simpson, et al.
Nature
|
October 19, 2018
Ceramic-metal composites for heat exchangers in concentrated solar power plants
M Caccia, M Tabandeh-Khorshid, G Itskos, et al.
Journal of Medicinal Chemistry
|
February 18, 2022
Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles
Edgars Jecs, Yesim A Tahirovic, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors
Amy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Cancer
|
June 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis
Koji Sasaki, Hagop M Kantarjian, Kiyomi Morita, et al.
Page
of 72
Search research articles
Search
Showing results (681-690 of 718) with videos related to
Sort By:
Page
of 72
ACS Medicinal Chemistry Letters
|
October 22, 2021
Amino-Heterocycle Tetrahydroisoquinoline CXCR4 Antagonists with Improved ADME Profiles via Late-Stage Buchwald Couplings
Huy H Nguyen, Yesim A Tahirovic, Valarie M Truax, et al.
Journal of Medicinal Chemistry
|
April 6, 2026
Discovery of Novel 2-Morpholine Tetrahydroisoquinoline CXCR4 Antagonists with Unique Properties
Yesim Altas Tahirovic, Zafer Sahin, Edgars Jecs, et al.
Space Science Reviews
|
February 6, 2026
Geodetic Investigations of the Europa Clipper Mission
G Steinbrügge, R S Park, J H Roberts, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 8, 2001
Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7
G Sansig, T J Bushell, V R Clarke, et al.
Journal of Medicinal Chemistry
|
January 20, 2018
Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties
Eric J Miller, Edgars Jecs, Valarie M Truax, et al.
Brain Structure & Function
|
August 21, 2025
Multi-centre normative brain mapping of intracranial EEG lifespan patterns in the human brain
Heather Woodhouse, Gerard Hall, Callum Simpson, et al.
Nature
|
October 19, 2018
Ceramic-metal composites for heat exchangers in concentrated solar power plants
M Caccia, M Tabandeh-Khorshid, G Itskos, et al.
Journal of Medicinal Chemistry
|
February 18, 2022
Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles
Edgars Jecs, Yesim A Tahirovic, Robert J Wilson, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors
Amy C Hart, Gretchen M Schroeder, Honghe Wan, et al.
Cancer
|
June 17, 2021
Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis
Koji Sasaki, Hagop M Kantarjian, Kiyomi Morita, et al.
Page
of 72